Evaluation of sentinel lymph node biopsy in clinically node-negative breast cancer

Journal of Nippon Medical School

Volumn 78, Issue 2, 2011, Pages 96-100

  Iida, Shinya ^a   Haga, Shunsuke ^a   Yamashita, Koji ^b   Yanagihara, Keiko ^a   Kurita, Tomoko ^a   Murakami, Ryusuke ^b   Shin Ichiro, Kumita ^b   Shin Ichi, Tsuchiya ^a   Furukawa, Kiyonori ^a   Uchida, Eiji ^a  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; Sentinel lymph node; Sentinel lymph node biopsy; Sentinel node biopsy

Indexed keywords

COLLOID TC 99M;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MICROMETASTASIS; NODE NEGATIVE BREAST CANCER; PARTIAL MASTECTOMY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; VALIDITY;

BREAST; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; MALE; SENTINEL LYMPH NODE BIOPSY;

EID: 79955430627     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.78.96     Document Type: Article

References (25)

1. Goldhirsch A, Ingle JN, Gelber RD, et al.: Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009; 20: 1319-1329.
2. Veronesi U, Paganelli G, Viale G, et al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349: 546-553.
3. Langer I, Guller U, Berclaz G, et al.: Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 2006; 245: 452-461.
4. Turner RR, Ollila DW, Kranse DL, et al.: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271-278.
5. Krag DN, Anderson SJ, Julian TB, et al., for the National Surgical Adjuvant Breast and Bowel Project (NSABP): Technical outcomes of Sentinellymph-node resection and conventional axillarylymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomized phase III trial. Lancet Oncol 2007; 8: 881-888.
6. Mansel RE, Lesley FL, Kissin M, et al.: Randomized multicenter trial of node biopsy versus standard axillary treatment in operable breast cancer, the ALMANAC trial. J Natl Cancer Inst 2006; 98: 599-609.
7. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350.
8. Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS: Implementation of a new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol 1999; 6: 553-561.
9. General Rules for Clinical and Pathological Recording of Breast cancer 2005. Breast cancer 2005; 12 Suppl: 1-14.
10. A Multicenter-based Phase II Study on the Safety of Sentinel Lymph Node Biopsy for Primary Breast Cancer without Clinical Aaxillary Lymph Node Metastasis. Jpn J Breast Cancer 2009; 24: 271-277 (in Japanese).
11. Singletary SE, Allred C, Ashley P, et al.: Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 2002; 20: 3628-3636.
12. Alvarez S, et al.: Role of sonography in the diagnosis of axillary lymph node metastasis in breast cancer: a systematic review. Am J Roentogenol 2006; 186: 1342-1348.
13. Heusner TA, et al.: Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging 2009; 36: 1543-1550.
14. Ogasawara Y, et al.: Multidetector-row computed tomography for the preoperative evaluation of axillary nodal status in patients with breast cancer. Surg Today 2008; 38: 104-108.
15. Mumtaz H, et al.: Staging of symptomatic primary breast cancer with MR imaging. Am J Roentgenol 1997; 169: 417-424.
16. Veronesi U, Paganelli G, Viale G, et al.: Sentinellymph-node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet Oncol 2006; 7: 983-990.
17. Scoggins CR, Chagpar AB, Martin RCG, McMasters KM: Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers? Nature Clin Practice Oncol 2005; 2: 448-455.
18. Uren RF, Howman-Giles RB, Thompson JF, et al.: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1997; 36: 1775-1780.
19. Noguchi M, Motomura K, Imoto S, et al.: A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 2000; 63: 31-40.
20. Roumen RM, Geuskens LM, Valkenburg JG: In search of the true sentinel node by different injection technique in breast cancer patients. Eur J Surg 1999; 25: 347-351.
21. Tamaki Y, Akiyama F, Iwase T, et al.: Molecular Detection of Lymph Node Metastasis in Breast Cancer Patients: Results of a Multicenter Trial Using the One-Step Nucleic Acid Amplification Assay. Clin Cancer Res 2009; 15: 2879-2884.
22. White RL Jr, Wilke LG: Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 2004; 70: 420-424.
23. European Organization for the Research and Treatment of Cancer (EORTC) Breast Cancer Cooperative Group: In EORTC Protocol 10981: After Mapping of the Axilla: Radiotherapy or Surgery (AMAROS), 1999; EORTC Data Center, Brussels.
24. Clarke D, Khonji NI, Mansel RE: Sentinel node biopsy in breast cancer: ALMANAC trial. World J Surg 2001; 25: 819-822.
25. Gill PG: Sentinel lymph node biopsy versus axillary clearance in operable breast cancer: The RACS SNAC trial, a multicenter randomized trial of the Royal Australian College of Surgeons (RACS) Section of Breast Surgery, in collaboration with the National Health and Medical Research Council Clinical Trials Center. Ann Surg Oncol 2004; 11 (Suppl 3): 216s-